PRIA Logo™
DelawareHB 429153rd General Assembly (2024–2026)HouseWALLET

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO THE STEP THERAPY EXCEPTION PROCESS.

Sponsored By: Melissa Minor-Brown (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

Patients can face more drug coverage steps

Delaware expands its step-therapy exception rules, which govern trying another medicine before insurance covers a brand-name drug. Insurers, health plans, and drug coverage reviewers can now require patients to try a biosimilar or interchangeable biological product first. These are alternatives to brand-name biologic medicines. The existing option to require an AB-rated generic equivalent remains. The law allows these treatment steps but does not require plans to use them.

Sponsors & Cosponsors

Sponsor

  • Melissa Minor-Brown

    Democratic • House

Cosponsors

  • Alonna Berry

    Democratic • House

  • Frank Burns

    Democratic • House

  • William J. Carson

    Democratic • House

  • Kerri Evelyn Harris

    Democratic • House

  • Debra Heffernan

    Democratic • House

  • Kendra Johnson

    Democratic • House

  • Larry Lambert

    Democratic • House

  • Eric Morrison

    Democratic • House

  • Marie Pinkney

    Democratic • Senate

  • Nicole Poore

    Democratic • Senate

  • Melanie Ross Levin

    Democratic • House

  • Ray Seigfried

    Democratic • Senate

  • Claire Snyder-Hall

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 59 • No: 1

Senate vote • 6/24/2026

Passed (3/4 required)

Yes: 21 • No: 0

House vote • 6/11/2026

Passed (3/4 required)

Yes: 38 • No: 1

Actions Timeline

  1. Signed by Governor

    7/23/2026Governor

  2. Passed By Senate. Votes: 21 YES

    6/24/2026Senate

  3. Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 5 On Its Merits

    6/23/2026Senate

  4. Assigned to Banking, Business, Insurance & Technology Committee in Senate

    6/11/2026Senate

  5. Passed By House. Votes: 38 YES 1 NO 2 ABSENT

    6/11/2026House

  6. Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 6 On Its Merits

    6/9/2026House

  7. Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

    5/19/2026House

Bill Text

  • Current

    5/19/2026

    HTML

Related Bills

Back to State Legislation